Paul Christopher Williams - 18 Aug 2023 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Chief Operating Officer
Signature
/s/ Valerie Barnett, Attorney-in-Fact for Paul Christopher Williams
Issuer symbol
CTKB
Transactions as of
18 Aug 2023
Transactions value $
-$3,037
Form type
4
Date filed
21 Aug 2023, 21:16
Previous filing
19 May 2023
Next filing
21 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTKB Common Stock Options Exercise +920 +245.99% 1.29K 18 Aug 2023 Direct F1
transaction CTKB Common Stock Tax liability -$3.04K -359 -27.74% $8.46 935 18 Aug 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Restricted Stock Units Options Exercise $0 -920 -6.52% $0.00 13.2K 18 Aug 2023 08/18/2023 920 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
F2 Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
F3 The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.